Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Similar documents
Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Biopsy Features of Kidney Allograft Rejection Banff B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts

Interpretation of Renal Transplant Biopsy. Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Management of Rejection

Statement of Disclosure

Index. electron microscopy, 81 immunofluorescence microscopy, 80 light microscopy, 80 Amyloidosis clinical setting, 185 etiology/pathogenesis,

The Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference

RENAL EVENING SPECIALTY CONFERENCE

A clinical syndrome, composed mainly of:

Ordering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR

Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III

Recognition and Treatment of Chronic Allograft Dysfunction

Kidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA

Renal Pathology- Transplantation. Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH

Glomerular diseases mostly presenting with Nephritic syndrome

Surgical Pathology Report

Histopathological evaluation of renal allograft biopsies in Nepal: interpretation and significance

Glomerular pathology in systemic disease

Case Presentation Turki Al-Hussain, MD

Review of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology

Histopathology: Glomerulonephritis and other renal pathology

Glomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST

C1q nephropathy the Diverse Disease

Renal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs

Histopathological findings in transplanted kidneys

Year 2004 Paper one: Questions supplied by Megan

Kidneytransplant pathologyrelatedto immunosuppressiveagents

CHAPTER 2. Primary Glomerulonephritis

Rejection or Not? Interhospital Renal Meeting 10 Oct Desmond Yap & Sydney Tang Queen Mary Hospital

Dr Ian Roberts Oxford

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

Interstitial Inflammation

Acute renal failure (ARF) in the transplanted kidney represents a

Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus

Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification

Some renal vascular disorders

HLA and Non-HLA Antibodies in Transplantation and their Management

Histopathology: Hypertension and diabetes in the kidney These presentations are to help you identify basic histopathological features.

Immunopathology of T cell mediated rejection

Glomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin

RENAL HISTOPATHOLOGY

FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS

Chronic Active TCMR: clinical implications

Glomerular diseases with organized deposits

Interesting case seminar: Native kidneys Case Report:

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

Case Report A Clinical and Pathological Variant of Acute Transplant Glomerulopathy

Membranoproliferative Glomerulonephritis

renoprotection therapy goals 208, 209

CKD in Other Organ Transplants

Overview of glomerular diseases

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

Case 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016

Pathology of Complement Mediated Renal Disease

Diagnosis and Management of Acute and Chronic Humoral Rejection. Lars Pape

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

The Banff Conferences on renal allograft pathology the latest 2013 report

ACCME/Disclosure. Case #1. Case History. Dr. Bracamonte has nothing to disclose

Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab

Supplementary appendix

The Histology of Kidney Transplant Failure: A Long-Term Follow-Up Study

Clinical pathological correlations in AKI

Elevated Serum Creatinine, a simplified approach

The new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials

IMMUNOBIOLOGY OF TRANSPLANTATION. Wasim Dar

Mayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis

Impact of Subclinical Rejection on Transplantation

Histopathology: Vascular pathology

The Natural History of Chronic Allograft Nephropathy

James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant

Crescentic Glomerulonephritis (RPGN)

Deján Dobi, MD. PhD Thesis

Light and electron microscopical studies of focal glomerular sclerosis

The Value of Electron Microscopy in the Diagnosis of Chronic Renal Allograft Rejection

Special thanks to our clinical collaborators Special thanks to our patients. Administration. Andre Baretto

NEPHRITIC SYNDROME. By Dr Mai inbiek

Peritubular capillaries C4d deposits in renal allograft biopsies and anti HLA I/II alloantibodies screening Incidence and clinical importance

Case Presentation Turki Al-Hussain, MD

Update on Transplant Glomerulopathy

Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies

Journal of Nephropathology

Renal manifestations of IgG4-related systemic disease

Diabetes, Obesity and Heavy Proteinuria

substance staining with IgG, C3 and IgA (trace) Linear deposition of IgG(+), IgA.M(trace) and C3(+++) at the DEJ

Glomerulonephritis. Dr Rodney Itaki Anatomical Pathology Discipline.

HIV ASSOCIATED NEPHROPATHIES (HIVAN): 30 YEARS LATER

Familial DDD associated with a gain-of-function mutation in complement C3.

Research Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting Antibody-Mediated Rejection

Ανάπτυξη Βιοτράπεζας για την Ανίχνευση Πρώιμων Βιοδεικτών σε Ασθενείς με Χρόνια Νεφρική Νόσο

Pharmaceutical pathology

SCORING OF i-ifta: POTENTIAL RULES & ROLE IN CHRONIC TCMR

Nephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba

No evidence of C4d association with AMR However, C3d and AMR correlated well

Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection

Transcription:

Pathology of Kidney Allograft Dysfunction B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

The renal biopsy is a powerful tool in the diagnostic evaluation of allograft dysfunction

Evaluation procedure Standard At least two cores whenever possible Light microscopic stainings on serial sections (H&E, PAS, trichrome, methenamine silver) Immunostaining for complement 4d - indicator of antibody-mediated rejection

Optional LM: elastin staining - chronic rejection- induced intimal fibrosis IF: IgG, IgA, IgM, C3, C1q - GN tubular HLA-DR expression - acute T-cell-mediated rejection EM - chronic rejection, GN Implantation biopsy for comparison

Objective To review the pathology of rejection, CNI toxicity, polyomavirus nephropathy, and posttransplantation glomerulonephritis factors leading to end-stage kidney allograft disease Solez et al. Banff 07 Classification of Renal Allograft Pathology. AJT 8:753, 2008

Rejection Inflammatory response initiated by alloantigen recognition Acute T-cell mediated Alloantibody mediated Chronic Alloantibody mediated T-cell mediated

Acute T-cell-mediated rejection Inflammatory response against HLA class II antigens expressed on peritubular and glomerular capillary endothelial cells tubular epithelial cells interstitial dendritic cells mesangial cells

Acute T-cell-mediated rejection Inflammatory response against HLA class II antigens expressed on peritubular and glomerular capillary endothelial cells tubular epithelial cells interstitial dendritic cells mesangial cells Effector mechanisms CD8 + CTL-mediated cytotoxicity +++ Delayed type hypersensitivity + Antibody-dependent cytotoxicity +

Acute T-cell-mediated rejection Peritubular capillaries Interstitium Tubules Tubulointerstitial rejection + Arteries Vascular rejection + Glomeruli Transplant glomerulitis

Tubulointerstitial rejection Peritubular capillaritis: accumulation of lymphocytes + monocytes

Peritubular capillaritis on EM Hypertrophy of endothelial cells, accumulation and emigration of ly-s into the interstitium; CTL-mediated lysis Normal E-selectin ICAM-1 VCAM-1

Tubulointerstitial rejection Interstitial infiltrates rich in CTLs, oedema, tubular HLA-DR expression, and tubulitis CD8 +

Tubulitis: tubular expression of chemokines induce CTLs to invade the tubules; CTLs injure tubular epithelial cells CTL CTL Apo CTL Apo CTL CTL

Subsiding tubulointerstitial rejection: nodular infiltrates around newly formed lymphatic vessels; Tregs, CD4 +, CD8 +, CD68 + ; scanty tubulitis; oedema Ø

Differential diagnosis of tubulointerstitial rejection Acute pyelonephritis Infiltrates rich in neutrophils, neutrophilic tubulitis

Differential diagnosis of tubulointerstitial rejection Acute pyelonephritis - neutrophilic tubulitis Polyomavirus nephropathy - nuclear inclusion bodies Drug-induced TIN - faint tubular HLA-DR staining Post-transplant lymphoproliferative disease - predominance of B-lymphocytes

Vascular rejection Infiltration of the intima by lymphocytes + monocytes Involves the large arteries more frequently than the interlobular arteries

Differential diagnosis Intimal arteritis is pathognomic for acute T-cell-mediated rejection

Transplant glomerulitis Infiltration of the capillary loops by lymphocytes + monocytes Isolated transplant glomerulitis: in 10% of cases with acute T-cell-mediated rejection

Differential diagnosis Recurrent or de novo proliferative GN (rejection: no glomerular immune deposits)

Clinical correlation of acute T-cellmediated rejection Most common cause of a graft dysfunction in the first 3 months after Tx Sudden asymptomatic rise in the serum creatinine level

Outcome of acute T-cell-mediated rejection Tubulointerstitial rejection responds well to high-dose iv. steroid therapy Vascular rejection can be reversed with anti-lymphocyte antibody preparations If not: fibrous obliteration of arteries graft loss

Acute alloantibody-mediated rejection Donor-specific HLA class I antibodies Complement-mediated cytotoxic injury to the endothelial cells

Acute alloantibody-mediated rejection Donor-specific HLA class I antibodies Complement 4d degradation product binds to PTC endothelial cells This stable molecule is detected by IF Complement-mediated cytotoxic injury to the endothelial cells

Evaluation of C4d Immunofluorescence on frozen sections is more sensitive than immunohistochemistry on paraffin sections

Diagnostic criteria of acute alloantibodymediated reejction: C4d along PTCs; evidence of tissue injury; demonstration of donor-specific antibodies Evidence of tissue injury 1) ATN-like, minimal inflamm. 2) Capillary-NG margination and/or thromboses 3) Transmural arteritis and/or arterial fibrinoid necrosis Racusen et al. AJT 3:1-7, 2003

Cytotoxic injury to PTC endothelial cells manifests in lysis + apoptosis Liptak et al. AJT 5:2870, 2005

Differential diagnosis TMA secondary to CNI toxicity Anti-cardiolipin sy Recurrent HUS Viral infection due to CMV or parvovirus B19

Differential diagnosis TMA secondary to CNI toxicity Anti-cardiolipin sy Recurrent HUS Viral infection due to CMV or parvovirus B19 Clue None of these displays C4d positivity along the peritubular capillaries

Clinical correlation Infrequent (2-8%) Most common in the first few weeks after Tx; oligoanuria develops within days Therapeutic efforts may reverse the rejection process Poor prognosis

Chronic rejection Ongoing, smouldering alloimmune damage to the allograft, mediated predominantly by alloantibodies Vascular lesions are characteristic Transplant arteriopathy Transplant glomerulopathy Transplant capillaropathy

Vascular lesions of chronic rejection are associated with interstitial fibrosis and tubular atrophy (IF/TA)

Tx arteriopathy: new-onset intimal fibrosis Absence of elastosis

Tx arteriopathy is more pronounced in the arcuate and larger arteries than in the small arteries of the superficial cortex

Consequence Chronic progressive ischemic injury to the graft parenchyma

Tx glomerulopathy: double-contoured loops; EM: newly formed BM layer(s)

Consequences Proteinuria Focal glomerular obsolescence

Tx glomerulopathy may resemble to recurrent or de novo MPGN; no immunocomplexes on IF

Tx capillaropathy: circumferentially laminated BM; pathognomic: 5 or more BM layers; C4d+ along PTCs

Tx capillaropathy on light microscopy: thickened and laminated BMs; EM is more sensitive in the verification of TxC Well-functioning graft Chronic rejection

Consequence A progressive decrease in the number of PTCs

Diagnostic triad of chronic antibodymediated rejection 1) TxA, TxG, TxC either alone or in combination 2) Diffuse C4d deposition in PTCs 3) Presence of donor-specific antibody Solez et al. AJT 7:1-9, 2006

Chronic active T-cell-mediated rejection Lymphocytes in arterial intimal fibrosis

Clinical correlation of chronic rejection Major cause of graft loss after 1 year Insidious, progressive decline in the GFR, frequently accompanied by proteinuria (often in the nephrotic range) and hypertension

Calcineurin inhibitor toxicity Cyclosporin and tacrolimus can cause acute or chronic nephrotoxicity; the lesions are identical Acute toxicity Toxic tubulopathy Vascular toxicity - Acute arteriolopathy - TMA Chronic toxicity Hyaline arteriolopathy Liptak P, Ivanyi B. Nature Clin Pract Nephrol 2:398-404, 2006

Toxic tubulopathy Isometric vacuolization of the proximal straight tubules

The features of this tubulopathy cannot be distinguished from those of radiocontrast nephrotoxicity or osmotic nephrosis, Differential diagnosis conditions to be considered while making the diagnosis

Acute arteriolopathy: SMC injury; replacement of damaged myocytes by rounded plasma protein insudates

Clinical correlation Acute dysfunction The serum drug level is usually elevated Toxic tubulopathy is reversible Acute arteriolopathy may be irreversible

TMA: thrombi in glomerular capillary loops

Differential diagnosis CNI-induced TMA cannot be differentiated from other forms of TMA by morphology alone Pronounced arterial changes are not typical of CNI-induced TMA Acute humoral rejection (C4d+) Recurrent HUS

Clinical correlation Rare Resembles the HUS If the lesions are associated with extensive thrombosis, graft loss develops

Chronic toxicity: hyaline arteriolopathy The damaged SMCs are replaced by beaded hyaline deposits that bulge into the adventitia The insudates are positive for IgM and C3

Hyaline material (H) is present at sites where media SMCs have dropped out previously. E - swollen endothelial cells, A - apoptotic SMCs.

Hyaline arteriolopathy is associated with striped IF/TA

Differential diagnosis Hyalinosis in ageing, hypertension and diabetes: Mainly subendothelial and rarely extends into the adventitia Necrosis of the SMCs is not observed

Clinical correlation Chronic toxicity occurs several months after Tx; the incidence increases with time A slow, insidious rise in the serum creatinine level The kidney damage is irreversible

Ageing/hypertension: intimal fibroelastosis; subendothelial arteriolar hyalinosis; patchy segmental/global glomerulosclerosis; IF/TA

Polyomavirus nephropathy The BK polyomavirus exhibits tropism for the renal tubular epithelium, where it establishes latent infection Vigorous immunosuppression can lead to reactivation of the infection and the development of PVN The definitive diagnosis requires an allograft Bx Drachenberg et al. Hum Pathol 36:1245-1255, 2005

Viral replication results in cytopathic changes (nuclear enlargement, inclusion bodies, tubular cell injury)

Massive replication leads to cytolysis of tubular epithelial cells and interstitial inflammation

Immunostaining with SV40 large T-cell antigen confirms the diagnosis

EM is also diagnostic: the virions are 40 nm in diameter, arranged in a paracrystalloid structure

Differential diagnosis Other viral infections (adenovirus: 70-90 nm; CMV: 100-110 nm) Acute rejection (lack of nuclear inclusion bodies, intense tubular HLA-DR expression) Chronic rejection (lack of nuclear inclusion bodies, negative confirmatory tests) Liptak et al. Nature Clin Pract Nephrol 2:631-636, 636, 2006

Histologic patterns and clinical stages of PVN Pattern A Viral cytopathic changes with no or only minimal inflammation Early stage No dysfunction Urinary decoy cells Favorable prognosis Hirsch et al. Transplantation 79:1277-1286, 2005

Histologic patterns and clinical stages of PVN Pattern A Viral cytopathic changes with no or only minimal inflammation Pattern B Cytopathic and cytolytic changes with interstitial inflammation Early stage No dysfunction Urinary decoy cells Favorable prognosis Fully developed stage A gradually decreasing renal function Graft loss can exceed 50% Hirsch et al. Transplantation 79:1277-1286, 2005

Histologic patterns and clinical stages of PVN Pattern A Viral cytopathic changes with no or only minimal inflammation Pattern B Cytopathic and cytolytic changes with IS inflammation Pattern C IF/TA Variable cytopathic and inflammatory changes Early stage No dysfunction Urinary decoy cells Favorable prognosis Fully developed stage A gradually decreasing renal function Graft loss can exceed 50% Late/sclerosing stage A severe dysfunction Graft loss is likely Hirsch et al. Transplantation 79:1277-1286, 2005

T-cell-mediated rejection Peritubular capillaritis IS infiltrates rich in CTLs Lymphocytic tubulitis + Intimal arteritis + Glomerulitis Alloantibody-mediated rejection C4d+ along PTCs Evidence of tissue injury: - arterial fibrinoid necrosis - microthrombi - neutrophilic capillaritis - ischemic tubular damage Summary of acute lesions CNI toxicity Isometric vacuolation of tubules Early-stage hyalinization of individual myocytes in afferent arterioles

Summary of chronic lesions Rejection Arterial intimal fibrosis Double-contoured glomerular capillary loops PTC BM lamination IF/TA C4d+ along PTCs Ageing/hypertension Intimal fibroelastosis in arteries Nonspecific arteriolar hyalinosis Patchy glomerular sclerosis IF/TA CNI toxicity Hyaline arteriolopathy Patchy glomerular sclerosis Striped IF/TA Polyomavirus NP Cytopathic effects (inclusion bodies and tubular epithelial injury) A varying degree of IS inflammation, IF/TA

Post-transplantation transplantation glomerulonephritis Recurrences of GN tend to occur in the first few weeks after Tx De novo GN usually manifests at least a year after Tx

Post-transplantation transplantation glomerulonephritis FSGS, MPGN, IgAN and idiopathic diarrhea- negative HUS recur fequently Membranous nephropathy, FSGS, anti-gbm nephritis in Alport patients, and drug-induced TMA are the most common de novo diseases Recurrent or de novo GN often coexists with acute and/or chronic rejection and/or chronic CNI- toxicity, and contribute together to allograft loss Ivanyi B. Nature Clin Pract Nephrol 4:446-457, 457, 2008

Recurrent FSGS Proteinuria developed some days after the implantation. 1st Bx, EM: effacement of foot processes. 2. Bx (3 mo later). The FSGS lesion in two glomeruli

Coexistence of transplant GP and membranous NP Bx performed because of nephrotic sy that developed 26 mo after Tx.

Kidney allograft from a deceased donor ~10 years later: end-stage allograft disease

Kidney allograft from a deceased donor Early insults Late insults Additional insults The insults cumulate: end-stage allograft disease Nankivell BJ, Chapman JR. Transplantation 2006;81:643-654

Tx Early insults Ischemia reperfusion injury Acute tubular necrosis Acute/subclinical rejection Acute CNI toxicity Late insults Additional insults End-stage allograft disease

Tx Early insults Ischemia reperfusion injury Acute tubular necrosis Acute/subclinical rejection Acute CNI toxicity Late insults Chronic rejection Chronic CNI toxicity Polyomavirus NP Hypertension Recurrent/de novo glomerular disease Additional insults End-stage allograft disease

Tx Early insults Ischemia reperfusion injury Acute tubular necrosis Acute/subclinical rejection Acute CNI toxicity Additional insults Architectural degradation Cortical ischemia Persistent chronic inflamm. Accelerated ageing Cytokine excess Epithelial-mesenchymal transition and fibrosis Late insults Chronic rejection Chronic CNI toxicity Polyomavirus NP Hypertension Recurrent/de novo glomerular disease End-stage allograft disease

Renal allograft removed for end-stage kidney allograft failure The kidney is shrunken, the cortex is no longer separated from the medulla, and the large arteries display severe atherosclerosis

Conclusions The application of light microscopic stainings on serial sections the full immunofluorescence panel (C4d,( HLA IgG, IgA, IgM,, C3) tissue sampling for optional EM comparison with a time-zero biopsy C4d, HLA-DR, enables the pathologist to achieve etiologic diagnoses